“`html
Extensive Disclosures Highlight Competing Interests in Atrial Fibrillation Research
A recent analysis of disclosures from principal and consortium authors involved in atrial fibrillation research has brought too light a wide array of competing interests. These disclosures, adhering to the International Committee of Medical Journal Editors (ICMJE) uniform disclosure form, reveal financial ties, research grants, consulting fees, and board memberships that could possibly influence the objectivity of research findings.
Key Disclosures Among Principal Authors
Several principal authors reported significant relationships with industry stakeholders. For instance, D.K. declared support from various educational grants and research contracts, as well as consulting fees from companies like Bayer and Amomed. K.V.B. reported grants from the BHF and involvement with the British Society of Echocardiography education committee and the ESC.
P.S. disclosed grants from Boston, ImriCor, and CVRx, along with participation on advisory boards for Abbott, Medtronic, and biosense.M.S. reported grants from Biotronik, HammerMed, and Medtronic, as well as consulting fees and honoraria from multiple companies. L.M. declared research grants, consulting fees, and honoraria from Abbott Medical, Medtronic, Boston Scientific, and J&J, along with stock options in Galgo Medical, S.L.
E.G. reported grants from Consejo Superior de Deportes and Fondo de Investigaciones Sanitarias, while S.B. declared consulting fees from Medtronic, Boston Scientific, Microport, and Zoll. G.B. disclosed speakers’ fees from Bayer, Boston, Daiichi Sankyo, Sanofi, and Janssen. C.P.G.reported grants from the Alan Turing Institute, British Heart Foundation, NIHR, Horizon 2020, Abbott Diabetes Bristol-Myers Squibb, and ESC, along with consulting fees and honoraria from numerous companies.
T.J.R.D.P. declared consulting fees and honoraria paid to institutions from Adagio Medical, Volta Medical, Boston Scientific, and J&J. I.C.v.G. reported consulting fees from Bayer, participation on a data safety monitoring board for the PVI SHAM trial, and leadership roles within the EHRA and ESC. Several other principal authors, including S.M., K.R., Y.S.,and C.v.D., declared no competing interests.
Disclosures from Consortium Authors
Consortium authors also reported various competing interests.T.D. declared honoraria for lectures from Biosense and Abbott, consulting fees from Biotronik, and participation on advisory boards for Boston Scientific. B.G.-M. reported consulting fees from biotronik, Medtronic, Boston Sc, and Microport, along with participation on a data safety monitoring board for the BEAT AF Study and STOP DRUG Study.
M.L. disclosed consulting fees from Abbott and honoraria from Boston Scientific, while A. Mobley declared financial interests funded by the Cook and Wolstenholme Charitable Trust and the EU-Horizon and UKRI HYPERMARKER grant. T.R. reported grants from the NIHR and leadership roles within the Stroke Association and the British and Irish Association of Stroke Physicians.
E.M. declared research grants, consulting fees, and honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort, and Zoll. P. Baudinaud reported consulting fees from Medtronic, Abbott, and Boston Scientific, along with honoraria from IMPLICITY and participation on an advisory board for Medtronic. S.K. declared honoraria from the ESC, while U.R. reported grants from Bayer, consulting fees from Boehringer Ingelheim and Sanofi, and honoraria from multiple companies.
M. Proietti declared financial interests related to the AFFIRMO project, and S.T. reported grants from the ESC,honoraria from Abbott,Boston Scientific,and Astra Zeneca,and support for attending meetings from Boston Scientific. P. Buchta disclosed consulting fees from the ESC, honoraria from johnson & Johnson and Abbott, and support for attending meetings. I.R.L. reported consulting fees, honoraria, and support for attending meetings from Abbott Medical, Biosense Webster, and Boston Scientific. D.T. declared honoraria from Abbott and Medtronic.
A.S. reported consulting fees from Astra Zeneca, Rhythm AI, and Reachora, along with honoraria from Abbott Medical and support for attending meetings from Biosense Webster. O.P. disclosed consulting fees from BMS Pfizer, Abbott, and Zoll Medical, along with honoraria from BMS Pfizer and abbott and leadership roles within the French Society Cardiology and EHRA.C.D.C. reported grants,royalties,honoraria,and support for attending meetings from Biosense Webster,Abbott,and Boston scientific,along with patents planned,issued,or pending.
M.D.G.declared honoraria from Abbott and Medtronic,while E.G. reported consulting fees from Boston, Medtronic, Microport, and Biotronik, along with support for attending meetings and participation on an advisory board for Boston. F.S. disclosed speaker fees and support for attending meetings from Abbott,Biosense,Webster,Boston Scientific,Medtronic,and Microport. C.G. reported consulting fees from Pfizer and Medtronic, along with honoraria from Abbott and boston Scientific.
S.W. declared grants, consulting fees, and speakers bureau activities from Abbott and Boston, along with participation on an advisory board. M. Borlich reported consulting fees from Biosense Webster, speakers honoraria from Novartis and Bayer, and support for attending meetings from Boston Scientific. A. Metzner disclosed consulting fees and honoraria from Medtronic, Biosense Webster, Boston Scientific, Bayer, Bristol-Myers squibb, EPD-Philips, and Lifetech, along with support for attending meetings.
H.-H.E. reported grants, financial support, and research grants from Medtronic and ESC, along with payment for presentation from Biotronik. D.D. declared research grants,consulting fees,and honoraria from Abbott,Astra Zeneca,Bayer,Boehringer Ingelheim,Bristol Myer Squibbs,medtronic,Pfizer,Sanofi,and Zoll,along with participation on advisory boards and leadership roles within the EHRA. P.N. reported grants, consulting fees, and honoraria from Abbott, Amicus, Cardiac Dimensions, Daiichi, Chiesi, Idorsia, Sanofi, and Takeda, along with support for attending meetings.
R.R.T. declared consulting fees and speaker fees from Boston Scientific, Biotronik, Biosense Webster, and Abbott Medical, along with research grants from Abbott, Biosense Webster, and Lifetech. M. Bertini reported honoraria from Medtronic,Biotronik,Abbott,Microport,Boston,Bayer,Boherningher,Daiichi,and pfizer.S.F. declared grants from the ESC, while W.K.G. reported grants from the ESC, honoraria from Biotronik and the ‘Akademia Elektroterapii’ Journal, and support for attending meetings from Biotronik, Abbott, and Medtronic.
F.B. declared grants from Boston Scientific, while J.O. reported honoraria and support for attending meetings. J.L.M. disclosed honoraria from Abbott, Milestone Pharmaceuticals, Biotronik, AstraZeneca, Microport, and Zoll, along with support for attending meetings from Bayer and Zoll and participation on an advisory board for Medtronic and Sanofi. N.R.-G. reported research and teaching grants, consulting fees, honoraria, payment for expert testimony, and support for attending meetings from Abbott, Medtronic, Boston Scientific, and Johnson & Johnson, along with leadership roles within the Ritmo Society Accreditation Committee and Spanish Cardiology Society.
E.T. declared grants, consulting fees, honoraria, and support for attending meetings from Abbott, Biotronik, and Medtronic. F.S.N. reported grants from the British Heart Foundation, the National Institute for Health Research, and the Medical research Council. M.J.L.disclosed honoraria from Bisosense-Webster, fees for proctoring cases and lectures, and support for attending meetings paid to the institution, along with leadership roles within NHS England and NICOR.
M.F. declared grants, consulting fees, honoraria, support for attending meetings, patents planned, issued, or pending, leadership roles within the EHRA Certification committee, and stock or stock options in Rhythm AI Ltd, Echopoint Medical Ltd., and Epicardio Ltd. H.H. reported grants, speakers fees, and unpaid participation on a data safety monitoring board from Universities of hasselt and Antwerp, Abbott, Medtronic, Biotronik, Boston Scientific, Bayer, Boehringer
